EPO communicates intention to grant Nanexa’s PharmaShell® patent in Europe

7 July, 2021
- Press Release

Nanexa AB is pleased to announce that the European Patent Office (EPO) has today issued a communication advising that it intends to grant a European patent relating to Nanexa’s PharmaShell® technology.

Following completion of some internal checks and the necessary formal requirements, a patent will grant, all being well, within the next few months.